Sangamo Therapeutics Stock Forecast

OTC-SGMO's stock price has decreased by -60.89% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Sangamo Therapeutics stock has a consensus rating of "Buy" and an average price target of $3.75. The average 1-year stock price forecast is 1,925.93% higher than the current stock price, while the lowest is $1.00 (+440.25%) and the highest is $10 (+5,302.49%).

Price Target: $3.75 (+1,925.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$3.75	$2.00	$10
Change	+440.25%	+1925.9%	+980.50%	+5302.5%

Analyst Ratings

The average analyst rating for Sangamo Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	3	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luca Issi RBC Capital	RBC Capital	Hold Maintains $2	Hold	Maintains	$2	+980.50%	May 15, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $10	Buy	Reiterates	$10	+5,302.49%	Apr 29, 2026
Unknown Analyst Wells Fargo No rating	Wells Fargo	Hold Maintains $4 → $2	Hold	Maintains	$4 → $2	+980.50%	Jan 5, 2026

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.